Publisert 30.01.2018

Eurostars/BIA aplication results q4 2018

....close, above treshold, but limited national funding.

Publisert 04.10.2017

Eurostars/BIA application results q4 2018

 

 On December 19th 2018 and January 30th 2019 Regenics recieved an above treshold rating for both applications to Eurostars and BIA in the cut-off 2 2018 Eurostars program and annual BIA programme. The national funding schemes however did not grant the funding requested by Regenics and partner RISE in Sweden . A resubmissioin of application on February 28th has been agreed for the Eurostars programme at this stage.

The Eurostars research program is a highly competitve option for SME funding to leading near market projects, approximately 20-25% reaches above threshold and again approx. 1/3 can achieve national funding.  Regenics has previoiusly recievced Eurostars funding and due to the  fierce competition for funding every year, Regenics, with partner RISE of Sweden, have decided to resubmit an amended application to Eureka at February 28th 2019, for the cut-off 1 2019 call.

A possible resubmission to BIA will be communicated in q2 2019.

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.